SCHEMBL21213367

SCHEMBL21213367

c1ccc2cc3c(cc2c1)c1ccccc1n3-c1nc2ccccc2nc1-c1ccc2ccc3ccccc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HIF1A Q16665 1/20 0.38
CYP1B1 Q16678 1/20 0.38
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36
TUBB6 Q9BUF5 1/20 0.36
TUBB2B Q9BVA1 1/20 0.36
TUBB1 Q9H4B7 1/20 0.36
ESR1 P03372 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21213631 0.94 TUBB4A (0.37) ALDH1A1HSD17B10HIF1ACYP1B1TUBB4A
SCHEMBL21213369 0.94 TUBB4A (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21716261 0.93 HPGD (0.33) ALDH1A1HSD17B10HIF1ACYP1B1TUBB4A
SCHEMBL21716914 0.93 HPGD (0.33) ALDH1A1HSD17B10HIF1ACYP1B1TUBB4A
SCHEMBL21716785 0.93 HPGD (0.33) ALDH1A1HSD17B10HIF1ACYP1B1TUBB4A
SCHEMBL21716930 0.93 HPGD (0.33) ALDH1A1HSD17B10HIF1ACYP1B1TUBB4A
SCHEMBL21213628 0.92 ESR1 (0.35) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL21923536 0.91 ESR1 (0.39) ALDH1A1HSD17B10HIF1ACYP1B1ESR1
SCHEMBL19655144 0.90 TUBB4A (0.42) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL21213432 0.89 TUBB4A (0.40) HSD17B10TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-02-14 US disclosed
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1B1, CYP2C9, CYP3A4 ALDH1A1 57/4885HSD17B10 581/4885HIF1A 2128/4885
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same CYP1B1, CYP2C9, CYP3A4 ALDH1A1 57/4885HSD17B10 581/4885HIF1A 2128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.